This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 134 words of the full text and any section headings.

To the Editor: The Clinical Review by Dr Gluckman and colleagues¹ on the management of non–ST-segment elevation acute coronary syndromes suggests considering the addition of niacin to statins if high-density lipoprotein cholesterol levels are less than 40 mg/dL (1.0 mmol/L) or triglyceride levels are greater than 150 mg/dL (1.7 mmol/L). However, niacin can be dangerous and might even increase myocardial ischemia in the acute setting.² This may occur on the basis of coronary steal and/or lowering coronary perfusion pressure due to the vasodilating properties of niacin.

Niacin is an excellent lipid-lowering drug to use alone³ or in combination with a statin⁴ for the prevention of coronary heart disease. However, I believe that if niacin is used, it should never be started during an acute coronary event but should be delayed at least several weeks.

Mark R. Goldstein, MD
markrgoldstein@comcast.net
Cleveland Clinic Florida
Naples

1. Gluckman TJ, Sachdev M, Schulman SP, Blumenthal RS. A simplified approach to the management of non–ST-segment elevation acute coronary syndromes. JAMA. 2005;293:349-357. FREE FULL TEXT 2. Pasternak RC, Kolman BS. Unstable myocardial ischemia after the initiation of niacin therapy. Am J Cardiol. 1991;67:904-906. FULL TEXT | ISI | PUBMED 3. Canner PL, Berge KG, Wenger NK, et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol. 1986;8:1245-1255. ABSTRACT 4. Brown BG, Zhao X-Q, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345:1583-1592. FREE FULL TEXT

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2005;293:2092-2093.

RELATED ARTICLES

Use of Niacin During Non–ST-Segment Elevation Acute Coronary Syndromes—Reply
Ty J. Gluckman, Molly Sachdev, Steven P. Schulman, and Roger S. Blumenthal
JAMA. 2005;293(17):2093.
EXTRACT | FULL TEXT  

A Simplified Approach to the Management of Non–ST-Segment Elevation Acute Coronary Syndromes
Ty J. Gluckman, Molly Sachdev, Steven P. Schulman, and Roger S. Blumenthal
JAMA. 2005;293(3):349-357.
ABSTRACT | FULL TEXT